Brandywine Global Investment Management’s Myriad Genetics MYGN Stock Holding History

Brandywine Global Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,164	Closed	-$119K	–	984
2016 Q1	$119K	Sell	3,164 -120,300	-97%	-$4.53M	﹤0.01%	756
2015 Q4	$5.33M	Sell	123,464 -74,247	-38%	-$3.14M	0.03%	420
2015 Q3	$7.41M	Sell	197,711 -135,220	-41%	-$4.8M	0.05%	344
2015 Q2	$11.3M	Sell	332,931 -3,560	-1%	-$121K	0.07%	251
2015 Q1	$11.9M	Buy	336,491 +151,222	+82%	+$5.41M	0.08%	238
2014 Q4	$6.31M	Hold	185,269	–	–	0.04%	385
2014 Q3	$7.15M	Buy	185,269 +35,748	+24%	+$1.33M	0.05%	331
2014 Q2	$5.82M	Buy	+149,521	New	+$5.56M	0.05%	348

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Brandywine Global Investment Management's MYGN Position: Q2 2016 in Review

Brandywine Global Investment Management sold out of Myriad Genetics (MYGN) in Q2 2016, closing a stake of 3,164 shares — an estimated $119K sold.

Brandywine Global Investment Management first reported a position in MYGN in Q2 2014 and held it in 8 quarters. The position peaked at $11.9M in Q1 2015. 252 funds tracked by Wall St. Rank hold MYGN as of Q2 2016.

Brandywine Global Investment Management reported no remaining Myriad Genetics position as of Q2 2016 after selling out during the quarter.
Brandywine Global Investment Management sold 3,164 Myriad Genetics shares in Q2 2016, an estimated $119K.
Brandywine Global Investment Management first reported a position in Myriad Genetics in Q2 2014 and held it in 8 quarters.
Brandywine Global Investment Management's Myriad Genetics position peaked at $11.9M in Q1 2015.
252 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2016.

Based on Brandywine Global Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.